116 related articles for article (PubMed ID: 1476266)
1. Fibrinolytic enhancement in diabetic microangiopathy with defibrotide.
Belcaro G; Marelli C; Pomante P; Laurora G; Cesarone MR; Ricci A; Girardello R; Barsotti A
Angiology; 1992 Oct; 43(10):793-800. PubMed ID: 1476266
[TBL] [Abstract][Full Text] [Related]
2. Microcirculatory effects of elastic stockings in diabetic microangiopathy: a 24-week study.
Belcaro G; Laurora G; Cesarone MR; De Sanctis MT; Incandela L
J Cardiovasc Surg (Torino); 1993 Dec; 34(6):479-82. PubMed ID: 8300711
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Ibudilast on lower limb circulation of diabetic patients with minimally impaired baseline flow: a study using color Doppler ultrasonography and laser Doppler flowmetry.
Sone H; Okuda Y; Asakura Y; Asano M; Mizutani M; Bannai C; Yamashita K
Angiology; 1995 Aug; 46(8):699-703. PubMed ID: 7639416
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolytic effects of defibrotide in atherosclerotic patients.
Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella asiatica: a clinical prospective randomized trial with a microcirculatory model.
Cesarone MR; Incandela L; De Sanctis MT; Belcaro G; Bavera P; Bucci M; Ippolito E
Angiology; 2001 Oct; 52 Suppl 2():S49-54. PubMed ID: 11666124
[TBL] [Abstract][Full Text] [Related]
6. Microcirculation in high perfusion microangiopathy.
Belcaro G; Laurora G; Cesarone MR; De Sanctis MT; Incandela L
J Cardiovasc Surg (Torino); 1995 Aug; 36(4):393-8. PubMed ID: 7593154
[TBL] [Abstract][Full Text] [Related]
7. Effect of a new antithrombotic agent (defibrotide) in acute renal failure due to thrombotic microangiopathy.
Bonomini V; Frascà GM; Raimondi C; Liviano D'arcangelo G; Vangelista A
Nephron; 1985; 40(2):195-200. PubMed ID: 3839050
[TBL] [Abstract][Full Text] [Related]
8. Diabetic microangiopathy treated with elastic compression--a microcirculatory evaluation using laser-Doppler flowmetry, transcutaneous PO2/PCO2 and capillary permeability measurements.
Belcaro G; Christopoulos A; Nicolaides AN
Vasa; 1990; 19(3):247-51. PubMed ID: 2238820
[TBL] [Abstract][Full Text] [Related]
9. Defibrotide therapy for thrombophlebitis--controlled clinical trial.
Di Perri T; Vittoria A; Messa GL; Cappelli R
Haemostasis; 1986; 16 Suppl 1():42-7. PubMed ID: 3754835
[TBL] [Abstract][Full Text] [Related]
10. Skin flow the venoarteriolar response and capillary filtration in diabetics. A 3-year follow-up.
Belcaro G; Nicolaides AN; Volteas N; Leon M
Angiology; 1992 Jun; 43(6):490-5. PubMed ID: 1595943
[TBL] [Abstract][Full Text] [Related]
11. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
Skrha J; Prázný M; Kvasnicka J; Kalvodová B
Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186
[TBL] [Abstract][Full Text] [Related]
12. The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.
Echart CL; Graziadio B; Somaini S; Ferro LI; Richardson PG; Fareed J; Iacobelli M
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):627-34. PubMed ID: 19809307
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the local effects of vitamin E (E-Mousse) on free radicals in diabetic microangiopathy: a randomized, controlled trial.
Ruffini I; Belcaro G; Cesarone MR; Geroulakos G; Di Renzo A; Milani M; Coen L; Ricci A; Brandolini R; Dugall M; Pomante P; Cornelli U; Acerbi G; Corsi M; Griffin M; Ippolito E; Bavera P
Angiology; 2003; 54(4):415-21. PubMed ID: 12934761
[TBL] [Abstract][Full Text] [Related]
14. Disturbances of cutaneous microcirculation in patients with diabetic legs: additional parameters for a new therapeutic concept?
Bühler-Singer S; Hiller D; Albrecht HP; Seidel C; Hornstein OP
Acta Derm Venereol; 1994 Jul; 74(4):250-6. PubMed ID: 7976079
[TBL] [Abstract][Full Text] [Related]
15. Deficient fibrinolytic response in patients with Raynaud's phenomenon and its correction with defibrotide.
Cimminiello C; Milani M; Pietra A; Rossi F; Aloisio M; Nazzari M; Bonfardeci G
Semin Thromb Hemost; 1991; 17 Suppl 1():106-11. PubMed ID: 2068563
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of short-term defibrotide treatment of patients with atherosclerosis obliterans of the lower limbs.
Avellone G; Mandalà V; Pinto A; Martino A; Strano A
Haemostasis; 1986; 16 Suppl 1():55-8. PubMed ID: 2423422
[TBL] [Abstract][Full Text] [Related]
17. Evolution of superficial vein thrombosis treated with defibrotide: comparison with low dose subcutaneous heparin.
Belcaro G
Int J Tissue React; 1990; 12(5):319-24. PubMed ID: 2098372
[TBL] [Abstract][Full Text] [Related]
18. Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study.
Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Cipollone G; Acerbi G; Cacchio M; Del Boccio G; Di Renzo A; Stuard S; Corsi M
Angiology; 2006; 57(4):431-6. PubMed ID: 17022378
[TBL] [Abstract][Full Text] [Related]
19. [Clinical experience in patients with chronic peripheral obliterating arteriopathy: defibrotide versus definite molecular weight heparan sulfate (MW 7500-15000 dalton)].
Michelini S; Micci A; Failla A; Grechi G; Iantaffi A
Minerva Cardioangiol; 1996; 44(1-2):33-7. PubMed ID: 8767620
[TBL] [Abstract][Full Text] [Related]
20. Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy.
Steigerwalt R; Nebbioso M; Appendino G; Belcaro G; Ciammaichella G; Cornelli U; Luzzi R; Togni S; Dugall M; Cesarone MR; Ippolito E; Errichi BM; Ledda A; Hosoi M; Corsi M
Panminerva Med; 2012 Dec; 54(1 Suppl 4):11-6. PubMed ID: 23241930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
